Side effects that occurred with a frequency of 1% or less included the following: Gastrointestinal: dyspepsia, flatulence, mucositis, oral moniliasis, and gastritis Nervous System: headache, somnolence Allergic: bronchospasm Special Senses: taste perversion Adverse events reported with azithromycin during the post-marketing period in adult and/or pediatric patients for which a causal relationship may not be established include: Allergic: Arthralgia, edema, urticaria and angioedema Cardiovascular: Arrhythmias including ventricular tachycardia and hypotension
Cagrilintide is a long-acting amylin analogue it mimics a natural satiety hormone
Lilly now plans to submit a Biologics License Application (BLA) to the FDA in the first quarter of 2027, adding that it is currently completing the comprehensive Chemistry, Manufacturing and Controls (CMC) data package required for the BLA
National Osteoporosis Foundation
Hopefully well get to a point soon where these medicines will become a standard benefit. Trump Administration Actions The Centers for Medicare & Medicaid Services is starting a demonstration project this year that will allow some Medicare and Medicaid beneficiaries to access GLP-1s for obesity treatment
